119 related articles for article (PubMed ID: 8902250)
21. Platelet dopamine: D2 receptor binding in patients with migraine.
Shukla R; Khanna VK; Vinod P; Sankhwar ML; Yadav RS
Cephalalgia; 2009 May; 29(5):532-8. PubMed ID: 19170695
[TBL] [Abstract][Full Text] [Related]
22. Function of the peripheral serotoninergic pathways in migraine: a proposal for an experimental model.
Martelletti P; Stirparo G; Rinaldi C; Fusco BM
Cephalalgia; 1994 Feb; 14(1):11-5; discussion 4. PubMed ID: 7515328
[TBL] [Abstract][Full Text] [Related]
23. Platelet deactivation by 5HT2-receptor blockade parallels the antihypertensive response to ketanserin.
Amstein R; Fetkovska N; Pletscher A; Bühler FR
J Hypertens; 1989 Apr; 7(4):255-60. PubMed ID: 2723427
[TBL] [Abstract][Full Text] [Related]
24. [Therapy of drug-induced chronic headache. Recommendations of the German Migraine and Headache Society].
Diener HC; Pfaffenrath V; Soyka D; Gerber WD
Med Monatsschr Pharm; 1992 Apr; 15(4):106-9. PubMed ID: 1584111
[No Abstract] [Full Text] [Related]
25. Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes.
Bigal ME; Rapoport AM; Sheftell FD; Tepper SJ; Lipton RB
Cephalalgia; 2004 Jun; 24(6):483-90. PubMed ID: 15154858
[TBL] [Abstract][Full Text] [Related]
26. [Headache and dependence on mixed analgesic preparations].
Wörz R; Baar H; Draf W; Garcia J; Gerbershagen HU; Gross D; Magin F; Ritter K; Scheifele J; Scholl W
MMW Munch Med Wochenschr; 1975 Mar; 117(11):457-62. PubMed ID: 804624
[TBL] [Abstract][Full Text] [Related]
27. Expression of serotonin 5-HT(2A) receptors in the human cerebellum and alterations in schizophrenia.
Eastwood SL; Burnet PW; Gittins R; Baker K; Harrison PJ
Synapse; 2001 Nov; 42(2):104-14. PubMed ID: 11574947
[TBL] [Abstract][Full Text] [Related]
28. Serotonin 5-HT2A receptor binding in platelets from healthy subjects as studied by [3H]-lysergic acid diethylamide ([3H]-LSD): intra- and interindividual variability.
Spigset O; Mjörndal T
Neuropsychopharmacology; 1997 Apr; 16(4):285-93. PubMed ID: 9094146
[TBL] [Abstract][Full Text] [Related]
29. 5HT in migraine patients with medication-induced headache.
Hering R; Glover V; Pattichis K; Catarci T; Steiner TJ
Cephalalgia; 1993 Dec; 13(6):410-2. PubMed ID: 8313455
[TBL] [Abstract][Full Text] [Related]
30. [Long-term prognosis of analgesics abuse headache].
Takase Y; Kishigami H; Nakano M; Tatsumi C
Rinsho Shinkeigaku; 2005 Sep; 45(9):629-33. PubMed ID: 16248393
[TBL] [Abstract][Full Text] [Related]
31. [Headaches caused by abuse of symptomatic anti-migraine and analgesic treatment].
Taïmi C; Navez M; Perrin AM; Laurent B
Rev Neurol (Paris); 2001 Oct; 157(10):1221-34. PubMed ID: 11885515
[TBL] [Abstract][Full Text] [Related]
32. Spiperone: influence of spiro ring substituents on 5-HT2A serotonin receptor binding.
Metwally KA; Dukat M; Egan CT; Smith C; DuPre A; Gauthier CB; Herrick-Davis K; Teitler M; Glennon RA
J Med Chem; 1998 Dec; 41(25):5084-93. PubMed ID: 9836624
[TBL] [Abstract][Full Text] [Related]
33. Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors.
Hrdina PD; Bakish D; Chudzik J; Ravindran A; Lapierre YD
J Psychiatry Neurosci; 1995 Jan; 20(1):11-9. PubMed ID: 7865496
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five-year follow-up.
Schnider P; Aull S; Baumgartner C; Marterer A; Wöber C; Zeiler K; Wessely P
Cephalalgia; 1996 Nov; 16(7):481-5; discussion 461. PubMed ID: 8933992
[TBL] [Abstract][Full Text] [Related]
35. Platelet activation in muscle contraction headache and migraine.
Takeshima T; Shimomura T; Takahashi K
Cephalalgia; 1987 Dec; 7(4):239-43. PubMed ID: 2962739
[TBL] [Abstract][Full Text] [Related]
36. Fibromyalgia and headache. Failure of serotonergic analgesia and N-methyl-D-aspartate-mediated neuronal plasticity: their common clues.
Nicolodi M; Volpe AR; Sicuteri F
Cephalalgia; 1998 Feb; 18 Suppl 21():41-4. PubMed ID: 9533670
[TBL] [Abstract][Full Text] [Related]
37. [Headache caused by analgesic and/or ergotamine abuse].
Panconesi A; Del Bianco PL; Curradi C; Franchi G; Anselmi B; Andreini R
Clin Ter; 1991 May; 137(3):169-83. PubMed ID: 1831085
[TBL] [Abstract][Full Text] [Related]
38. Platelet 5-HT2 serotonin receptor binding sites in autistic children and their first-degree relatives.
Perry BD; Cook EH; Leventhal BL; Wainwright MS; Freedman DX
Biol Psychiatry; 1991 Jul; 30(2):121-30. PubMed ID: 1912104
[TBL] [Abstract][Full Text] [Related]
39. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A
Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660
[TBL] [Abstract][Full Text] [Related]
40. [Drug-induced headache].
Wallasch TM
Fortschr Neurol Psychiatr; 1992 Mar; 60(3):114-8. PubMed ID: 1349547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
